HealthEquity, Inc. (HQY)
NASDAQ: HQY · Real-Time Price · USD
104.37
+0.09 (0.09%)
Aug 21, 2026, 9:33 AM EDT - Market open
HealthEquity Income Statement
Financials in millions USD. Fiscal year is February - January.
Millions USD. Fiscal year is Feb - Jan.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 30, 2026 | Jan '26 Jan 31, 2026 | Jan '25 Jan 31, 2025 | Jan '24 Jan 31, 2024 | Jan '23 Jan 31, 2023 | Jan '22 Jan 31, 2022 |
| 1,337 | 1,313 | 1,200 | 999.59 | 861.75 | 756.56 | |
Revenue Growth | 7.58% | 9.47% | 20.03% | 16.00% | 13.90% | 3.13% |
Cost of Revenue | 392.11 | 400.31 | 422.52 | 376.95 | 369.81 | 331.79 |
Gross Profit | 945.12 | 913.12 | 777.26 | 622.64 | 491.94 | 424.77 |
Selling, General & Admin | 221.62 | 215.17 | 223 | 182.93 | 166.32 | 144.04 |
Research & Development | 268.84 | 262.51 | 239.51 | 218.81 | 193.38 | 157.36 |
Amortization of Goodwill & Intangibles | 107.47 | 107.95 | 111.88 | 92.76 | 94.59 | 82.79 |
Operating Expenses | 597.92 | 585.64 | 574.39 | 494.5 | 454.28 | 384.2 |
Operating Income | 347.19 | 327.48 | 202.87 | 128.13 | 37.65 | 40.57 |
Interest Expense | -54.86 | -57.13 | -60.63 | -55.46 | -48.42 | -36.57 |
Interest & Investment Income | 10.88 | 11.73 | 13.91 | 12.14 | 1.76 | 1.5 |
Other Non Operating Income (Expenses) | 0.54 | 0.38 | 0.42 | 0.66 | -0.44 | 1.71 |
EBT Excluding Unusual Items | 303.75 | 282.46 | 156.57 | 85.48 | -9.45 | 7.2 |
Merger & Restructuring Charges | -4.86 | -5.02 | -40.54 | -10.44 | -28.65 | -75.64 |
Gain (Loss) on Sale of Investments | - | - | - | - | - | 1.69 |
Pretax Income | 298.89 | 277.43 | 116.03 | 75.04 | -38.1 | -66.74 |
Income Tax Expense | 68.19 | 62.23 | 19.33 | 19.33 | -11.95 | -22.45 |
Net Income | 230.7 | 215.2 | 96.7 | 55.71 | -26.14 | -44.29 |
Net Income to Common | 230.7 | 215.2 | 96.7 | 55.71 | -26.14 | -44.29 |
Net Income Growth | 89.40% | 122.54% | 73.58% | - | - | - |
Shares Outstanding (Basic) | 86 | 86 | 87 | 86 | 84 | 83 |
Shares Outstanding (Diluted) | 87 | 87 | 89 | 87 | 84 | 83 |
Shares Change | -2.51% | -1.52% | 2.15% | 2.98% | 1.57% | 9.85% |
EPS (Basic) | 2.70 | 2.50 | 1.11 | 0.65 | -0.31 | -0.53 |
EPS (Diluted) | 2.67 | 2.46 | 1.09 | 0.64 | -0.31 | -0.53 |
EPS Growth | 94.81% | 125.69% | 70.31% | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 30, 2026 | Jan '26 Jan 31, 2026 | Jan '25 Jan 31, 2025 | Jan '24 Jan 31, 2024 | Jan '23 Jan 31, 2023 | Jan '22 Jan 31, 2022 |
Free Cash Flow | 487.64 | 455.13 | 337.77 | 241.13 | 147.28 | 132.09 |
Free Cash Flow Per Share | 5.63 | 5.20 | 3.80 | 2.77 | 1.74 | 1.59 |
Gross Margin | 70.68% | 69.52% | 64.78% | 62.29% | 57.09% | 56.15% |
Operating Margin | 25.96% | 24.93% | 16.91% | 12.82% | 4.37% | 5.36% |
Profit Margin | 17.25% | 16.38% | 8.06% | 5.57% | -3.03% | -5.85% |
Free Cash Flow Margin | 36.47% | 34.65% | 28.15% | 24.12% | 17.09% | 17.46% |
EBITDA | 501.32 | 482.14 | 365.32 | 281.21 | 198.85 | 177.76 |
EBITDA Margin | 37.49% | 36.71% | 30.45% | 28.13% | 23.08% | 23.49% |
D&A For EBITDA | 154.13 | 154.66 | 162.45 | 153.08 | 161.2 | 137.19 |
EBIT | 347.19 | 327.48 | 202.87 | 128.13 | 37.65 | 40.57 |
EBIT Margin | 25.96% | 24.93% | 16.91% | 12.82% | 4.37% | 5.36% |
Effective Tax Rate | 22.81% | 22.43% | 16.66% | 25.76% | - | - |
Revenue as Reported | 1,337 | 1,313 | 1,200 | 999.59 | 861.75 | 756.56 |